Discovery of Novel Chinese Medicine Compounds Targeting 3CL Protease by Virtual Screening and Molecular Dynamics Simulation
Molecules · 2023
DOI: 10.3390/molecules28030937 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, 2023. Verfasst von Jin Cheng und 11 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Jiangsu Vocational College of Medicine, Yancheng 224005, China. Hauptthemen laut MEDLINE: COVID-19. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Jiangsu Vocational College of Medicine, Higher Education of Jiangsu Education Department, Zhejiang Province science and technology plan projects.
Abstract (Originalsprache)
The transmission and infectivity of COVID-19 have caused a pandemic that has lasted for several years. This is due to the constantly changing variants and subvariants that have evolved rapidly from SARS-CoV-2. To discover drugs with therapeutic potential for COVID-19, we focused on the 3CL protease (3CLpro) of SARS-CoV-2, which has been proven to be an important target for COVID-19 infection. Computational prediction techniques are quick and accurate enough to facilitate the discovery of drugs against the 3CLpro of SARS-CoV-2. In this paper, we used both ligand-based virtual screening and structure-based virtual screening to screen the traditional Chinese medicine small molecules that have the potential to target the 3CLpro of SARS-CoV-2. MD simulations were used to confirm these results for future in vitro testing. MCCS was then used to calculate the normalized free energy of each ligand and the residue energy contribution. As a result, we found ZINC15676170, ZINC09033700, and ZINC12530139 to be the most promising antiviral therapies against the 3CLpro of SARS-CoV-2.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Pharmacy, Jiangsu Vocational College of Medicine, Yancheng 224005, China.
- Department of Pharmaceutical Sciences and Computational Chemical Genomics Screening Center, School of Pharmacy, National Center of Excellence for Computational Drug Abuse Research, University of Pittsburgh, Pittsburgh,…
- School of Pharmacy and Bioengineering, Chongqing University of Technology, Chongqing 400054, China.
- College of Pharmacology Sciences, Zhejiang University of Technology, Hangzhou 310014, China.
ORCID-Profile: Qin Shi
Förderung
- Natural Science Foundation of Jiangsu Vocational College of Medicine
- Higher Education of Jiangsu Education Department
- Zhejiang Province science and technology plan projects
Zitieren
APA
Cheng, J., Hao, Y., Shi, Q., Hou, G., Wang, Y., Wang, Y., Xiao, W., Othman, J., Qi, J., Wang, Y., Chen, Y., & Yu, G. (2023). Discovery of Novel Chinese Medicine Compounds Targeting 3CL Protease by Virtual Screening and Molecular Dynamics Simulation. Molecules. https://doi.org/10.3390/molecules28030937
Vancouver
Cheng J, Hao Y, Shi Q, Hou G, Wang Y, Wang Y, et al. Discovery of Novel Chinese Medicine Compounds Targeting 3CL Protease by Virtual Screening and Molecular Dynamics Simulation. Molecules. 2023. doi:10.3390/molecules28030937
BibTeX
@article{Cheng2023,
author = {Cheng, Jin and Hao, Yixuan and Shi, Qin and Hou, Guanyu and Wang, Yanan and Wang, Yong and Xiao, Wen and Othman, Joseph and Qi, Junnan and Wang, Yuanqiang and Chen, Yan and Yu, Guanghua},
title = {Discovery of Novel Chinese Medicine Compounds Targeting 3CL Protease by Virtual Screening and Molecular Dynamics Simulation},
journal = {Molecules},
year = {2023},
doi = {10.3390/molecules28030937}
}
EUVIMED